Literature DB >> 9176218

Characterization of sphingosine 1-phosphate-induced actions and its signaling pathways in rat hepatocytes.

D S Im1, T Fujioka, T Katada, Y Kondo, M Ui, F Okajima.   

Abstract

Sphingosine 1-phosphate (S-1-P) and lysophosphatidic acid (LPA) stimulated glycogen phosphorylase, a rate-limiting enzyme responsible for glycogenolysis, in association with Ca2+ mobilization and phospholipase C (PLC) activation in rat hepatocytes. S-1-P, but not LPA, also inhibited adenosine 3',5'-cyclic monophosphate accumulation reflecting adenylyl cyclase inhibition. S-1-P-induced PLC activation, Ca2+ mobilization, and phosphorylase activation were markedly enhanced by primary culture of the cells for 24 h, whereas the inhibitory adenosine 3',5'-cyclic monophosphate response was unchanged by increasing culture time. Activation of the PLC-Ca2+ system during primary culture was specific to the lysosphingolipid; PLC and Ca2+ responses to LPA and NaF were unchanged or slightly attenuated by increasing culture time. Pertussis toxin treatment almost completely suppressed the S-1-P-induced inhibition of adenylyl cyclase but hardly influenced the lipid-induced activation of PLC and its cascade reactions. We conclude that S-1-P, through an LPA receptor-independent mechanism, stimulates two signaling pathways, i.e., activation of the PLC-Ca2+ system and inhibition of adenylyl cyclase, through distinct S-1-P receptor-transducer systems, resulting in the modulation of glycogenolysis in rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176218     DOI: 10.1152/ajpgi.1997.272.5.G1091

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

3.  Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.

Authors:  N Murata; K Sato; J Kon; H Tomura; M Yanagita; A Kuwabara; M Ui; F Okajima
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.

Authors:  G C Zondag; F R Postma; I V Etten; I Verlaan; W H Moolenaar
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages.

Authors:  W W Lin; S H Chang; S M Wang
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3.

Authors:  T Kimura; T Watanabe; K Sato; J Kon; H Tomura; K Tamama; A Kuwabara; T Kanda; I Kobayashi; H Ohta; M Ui; F Okajima
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

7.  Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.

Authors:  A Bischoff; P Czyborra; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.

Authors:  Jason Michaud; Dong-Soon Im; Timothy Hla
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

Review 9.  Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.

Authors:  Yelena Drexler; Judith Molina; Alla Mitrofanova; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 14.978

Review 10.  Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.